Xencor
Utility Patent Applications
Last updated:
List of all Xencor patents 74 in total
| Status | Patent |
|---|---|
Application | Utility: Fc VARIANTS WITH ALTERED BINDING TO FcRn Filling date: 8 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: ICOS TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA Fc-FUSION PROTEINS AND ICOS ANTIGEN BINDING DOMAINS Filling date: 8 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: ENGINEERED IL-2 Fc FUSION PROTEINS Filling date: 8 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: BISPECIFIC AND MONOSPECIFIC ANTIBODIES USING NOVEL ANTI-PD-1 SEQUENCES Filling date: 8 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: IL15/IL15Ralpha HETERODIMERIC Fc-FUSION PROTEINS Filling date: 8 Sep 2025 Issue date: 23 Jun 2022 |
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS Filling date: 8 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND TGFbetaRII Filling date: 8 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: BISPECIFIC ANTIBODIES THAT BIND PD-L1 AND CD28 Filling date: 8 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: ANTI-CD28 COMPOSITIONS Filling date: 8 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) AND CD3 Filling date: 8 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: Fc VARIANTS WITH ALTERED BINDING TO FcRn Filling date: 8 Sep 2025 Issue date: 14 Apr 2022 |
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND MSLN AND CD3 Filling date: 8 Sep 2025 Issue date: 7 Apr 2022 |
Application | Utility: ANTI-CD28 COMPOSITIONS Filling date: 8 Sep 2025 Issue date: 31 Mar 2022 |
Application | Utility: TARGETED HETERODIMERIC Fc FUSION PROTEINS CONTAINING IL-15 IL-15alpha AND ANTIGEN BINDING DOMAINS Filling date: 8 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS Filling date: 8 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: IL-15/IL-15RA HETERODIMERIC FC FUSION PROTEINS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS Filling date: 8 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: TARGETED IL-12 HETERODIMERIC FC-FUSION PROTEINS Filling date: 8 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: Bispecific Antibodies That Bind to CD38 and CD3 Filling date: 8 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: HETERODIMERIC HUMAN IgG1 POLYPEPTIDES WITH ISOELECTRIC POINT MODIFICATIONS Filling date: 8 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: Fc VARIANTS WITH ALTERED BINDING TO FcRn Filling date: 8 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND FIBROBLAST ACTIVATION PROTEIN Filling date: 8 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND CHECKPOINT RECEPTORS Filling date: 8 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: NOVEL CTLA4-IG IMMUNOADHESINS Filling date: 8 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: PD-1 TARGETED IL-15/IL-15RALPHA FC FUSION PROTEINS WITH IMPROVED PROPERTIES Filling date: 8 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: Immunoprotection of Therapeutic Moieties Using Enhanced Fc Regions Filling date: 8 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: Fc VARIANTS THAT IMPROVE FcRn BINDING AND/OR INCREASE ANTIBODY HALF-LIFE Filling date: 8 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: ANTI-STEAP1 ANTIGEN-BINDING PROTEIN Filling date: 8 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: HETERODIMERIC PROTEINS Filling date: 8 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: Fc VARIANTS THAT IMPROVE FcRn BINDING AND/OR INCREASE ANTIBODY HALF-LIFE Filling date: 8 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: NOVEL HETERODIMERIC PROTEINS Filling date: 8 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: BISPECIFIC ANTIBODIES THAT BIND CD123 AND CD3 Filling date: 8 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: OPTIMIZED Fc VARIANTS Filling date: 8 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: Fc VARIANTS WITH ALTERED BINDING TO FcRn Filling date: 8 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: Fc VARIANTS WITH ALTERED BINDING TO FcRn Filling date: 8 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS Filling date: 8 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: COMPLEMENT COMPONENT C5 ANTIBODIES Filling date: 8 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: HETERODIMERIC IgG-LIKE BISPECIFIC ANTIBODIES Filling date: 8 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: BISPECIFIC ANTIBODIES THAT BIND CD20 AND CD3 Filling date: 8 Sep 2025 Issue date: 1 Apr 2021 |
Application | Utility: BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND CHECKPOINT RECEPTORS Filling date: 8 Sep 2025 Issue date: 1 Apr 2021 |
Application | Utility: DOSING OF A BISPECIFIC ANTIBODY THAT BINDS PD1 AND CTLA4 Filling date: 8 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS Filling date: 8 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS Filling date: 8 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: MODULATION OF T CELLS WITH BISPECIFIC ANTIBODIES AND FC FUSIONS Filling date: 8 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS Filling date: 8 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: OPTIMIZED ANTIBODIES THAT TARGET CD19 Filling date: 8 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: HETERODIMERIC ANTIBODIES THAT BIND ENPP3 AND CD3 Filling date: 8 Sep 2025 Issue date: 8 Oct 2020 |
Application | Utility: Fc VARIANTS WITH ALTERED BINDING TO FcRn Filling date: 8 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: Fc VARIANTS WITH ALTERED BINDING TO FcRn Filling date: 8 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: IL-12 HETERODIMERIC FC-FUSION PROTEINS Filling date: 8 Sep 2025 Issue date: 9 Jul 2020 |
Showing 1 to 50 of 74 patents.